• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Comprehensive Overview of 8-(Bromomethyl)-6-chloroquinoline (CAS No. 87293-40-1)

8-(Bromomethyl)-6-chloroquinoline (CAS No. 87293-40-1) is a versatile heterocyclic compound widely used in pharmaceutical and agrochemical research. This brominated quinoline derivative has garnered significant attention due to its unique structural properties, making it a valuable intermediate in organic synthesis. Researchers and industry professionals frequently search for terms like "8-(Bromomethyl)-6-chloroquinoline synthesis," "CAS 87293-40-1 applications," and "quinoline derivatives in drug discovery," reflecting its relevance in modern chemistry.

The molecular structure of 8-(Bromomethyl)-6-chloroquinoline features a quinoline core substituted with a bromomethyl group at the 8-position and a chloro group at the 6-position. This arrangement enhances its reactivity, enabling diverse transformations such as cross-coupling reactions and nucleophilic substitutions. Recent studies highlight its role in developing antimicrobial agents and fluorescence probes, aligning with growing interest in "quinoline-based therapeutics" and "bioimaging tools."

In pharmaceutical applications, 8-(Bromomethyl)-6-chloroquinoline serves as a precursor for kinase inhibitors and anticancer compounds. Its bromomethyl functionality allows facile conjugation with biomolecules, addressing trending topics like "targeted drug delivery" and "small-molecule modulators." Additionally, its chloroquinoline moiety contributes to metal-chelating properties, relevant to "metalorganic frameworks (MOFs)" research.

From an industrial perspective, this compound is pivotal in crop protection formulations. Searches for "agrochemical intermediates" often lead to 6-chloroquinoline derivatives, as they exhibit herbicidal and fungicidal activities. Innovations in "green chemistry" have also spurred interest in optimizing its synthesis to reduce environmental footprint.

Analytical characterization of CAS 87293-40-1 typically involves NMR spectroscopy, mass spectrometry, and HPLC purity analysis. These methods ensure compliance with stringent quality control standards, a key concern for laboratories focusing on "high-purity chemicals." Storage recommendations emphasize protection from moisture and light to maintain stability.

Emerging trends link 8-(Bromomethyl)-6-chloroquinoline to material science, particularly in designing organic semiconductors. Its electron-deficient quinoline ring aligns with searches for "optoelectronic materials," showcasing interdisciplinary potential. Future research may explore its utility in catalysis or renewable energy applications.

In summary, 8-(Bromomethyl)-6-chloroquinoline (CAS No. 87293-40-1) bridges multiple scientific domains, from medicinal chemistry to advanced materials. Its adaptability to current research demands—such as "precision medicine" and "sustainable agriculture"—ensures enduring relevance. Proper handling protocols and adherence to safety guidelines remain paramount for users worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)